n-Lorem Foundation CEO Publishes Important Perspective in Nucleic Acid Research
Invited Perspective Article [...]
n-Lorem Foundation and Ultragenyx United in Efforts to Help Nano-rare Patients
Ultragenyx’s continued support bolsters n-Lorem’s [...]
n-Lorem Foundation Introduces First ‘Partner in Excellence’ to Support and Accelerate the Treatment of Nano-rare Patients
Columbia University Irving Medical Center [...]
n-Lorem Launches its Patient Empowerment Program to Support Nano-rare Patients and Their Families
Program includes new podcast series [...]
n-Lorem Foundation and Columbia University Establish Silence ALS Initiative
Silence ALS initiative will offer [...]
n-Lorem Foundation Welcomes Amy McCooe to its Board of Directors
Amy McCooe’s leadership in integrating [...]
n-Lorem and The Wolverine Foundation Collaborate to Support the Discovery and Development of Personalized ASO Medicines for Nano-rare Patients
n-Lorem received a $3 million [...]
The Conrad Prebys Foundation to Support the Discovery and Development of Personalized ASO Medicines for Nano-rare Patients
n-Lorem awarded a $300,000 one-year [...]
La Jolla Labs and n-Lorem Foundation Partner to Discover Personalized ASO Medicines for Nano-rare Patients
Partnership leverages La Jolla Labs’ [...]
Second Anniversary for n-Lorem Foundation Marks Extraordinary Progress Toward Treating Nano-Rare Patients
n-Lorem’s donor and partner support [...]
